Search Results 1051-1060 of 17070 for monoclonal antibody
Children who developed Hib disease when 24 months of age or older do not need to be immunized, since most children in this age group will develop antibodies ...
Prior use of lenalidomide, or monoclonal antibodies against CTLA-4, PD-1, or PD-L1. High risk of developing thromboembolic events, who are unwilling to take ...
Has had prior anti-cancer monoclonal antibody (mAb), chemotherapy, targeted small molecule therapy, or radiation therapy within 4 weeks prior to the planned ...
A Study of Hematopoiesis in Patients with Monoclonal ... Monoclonal B Cell Lymphocytosis (MBL) and B ... antibodies) treatment, CPI-naïve hepatocellular ...
Use of rituximab, tocilizumab, or any monoclonal antibody/Fc-fusion biologic for immunomodulation within the past 9 months prior to Baseline. Use of ...
Mayo Clinic Q&A podcast: Herd immunity, antibodies and COVID-19. Jennifer O'Hara. July 31, 2020. Sharing Mayo Clinic. Voices of Mayo: Matthew Horace on Race in ...
... monoclonal antibodies < 28 days prior to randomization. Receipt of other investigational antiviral treatments (e.g., anti-BK monoclonal antibodies) within ...
PEGylation also reduces the production of new antibody and cellular immune responses against Ad. The Virology, Vector and Vaccine Engineering Lab has ...
Monoclonal antibodies: > 21 days must have elapsed from the infusion of last dose of antibody and toxicity related to antibody therapy must be recovered to ...
Anti-CD20 monoclonal antibody unless investigator determines that tumor is CD20 negative; and; An anthracycline containing chemotherapy regimen. Intent to ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make a gift before July 31 and it can be doubled in impact thanks to a $100,000 Summer Challenge.